top of page

OUR RESEARCH IMPACT

See below for the list of Triangulate's publications

A critical review of methodologies used in pharmaceutical pricing policy analyses.jpg

A critical review of methodologies used in pharmaceutical pricing policy analyses

Health Policy

Additional resource needs for viral hepatitis elimination through universal health coverag

Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30

The Lancet Global Health

An Urge to Act.jpg

THE HEALTH, SOCIO-ECONOMIC AND ENVIRONMENTAL COSTS OF CONTINENCE PROBLEMS IN THE EU

An Urge to Act - European Association of Urology

Bahrain NCD Investment Case.jpg

The burden of non-communicable diseases (NCDs) in Bahrain

UNDP

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus In

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income

Value in Health

Economic burden of female genital mutilation in 27 high-prevalence countries .jpg

Economic burden of female genital mutilation in 27 high-prevalence countries

BMJ Global Health

Evaluating medicine prices, availability and affordability in Bangladesh using World Healt

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology

BMC Health Services Research

Evidence on the effectiveness of policies promoting price transparency - A systematic revi

Evidence on the effectiveness of policies promoting price transparency - A systematic review

Health Policy

Final report of the Oslo Medicines Initiative.jpg

Final report of the Oslo Medicines Initiative

World Health Organization European Region

Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021.j

Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021

World Health Organization

Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing

Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss a modelling study

The Lancet Global Health

Kuwait NCD Investment Case.jpg

Joint Mission of the United Nations Interagency Task Force on the Prevention and Control of Noncommunicable Diseases

World Health Organization

Mechanisms used to reduce the price of antiretroviral medicines in Eastern Europe and Cent

Mechanisms used to reduce the price of antiretroviral medicines in Eastern Europe and Central Asia

Economist Impact

Operation Warp Speed, Encore.jpg

Operation Warp Speed, Encore: A Case for US Leadership to Drive Market-Based Global Health Innovation

Center for Global Development

Prevention and management of mental health conditions in The Philippines .jpg

Prevention and Management of Mental Health Conditions in the Philippines: The Case for Investment

United Nations Development Programme

Prevention and management of mental health conditions in Uzbekistan.jpg

Prevention and Management of Mental Health Conditions in Uzbekistan: The Case for Investment

United Nations Development Programme

Reaching Zero Dose and Under-Vaccinated Children in Eswatini.jpg

Reaching Zero Dose and Under-Vaccinated Children in Eswatini

UNICEF

Systematic review of rotavirus vaccination cost-effectiveness in high income settings util

Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques

Vaccine

Systematic reviews for the update of the WHO guideline on country pharmaceutical pricing p

Systematic reviews for the update of the WHO guideline on country pharmaceutical pricing policies

World Health Organization

Tackling antimicrobial resistance in healthcare.jpg

Tackling antimicrobial resistance in healthcare: the significance of robust health and economic data

Economist Impact

WHO guideline on country pharmaceutical pricing policies.jpg

WHO guideline on country pharmaceutical pricing policies

World Health Organization

World report on hearing 2021.jpg

World report on hearing

World Health Organization

Time to take gum disease seriously.jpg

Time to take gum disease seriously

The Economist Intelligence Unit

The reported impact of non-communicable disease investment cases in 13 countries .jpg

The reported impact of non-communicable disease investment cases in 13 countries 

BMJ Global Health

The value of action.jpg

The value of action: mitigating the impact of neurological disorders in the United Kingdom

Economist Impact

The Oslo Medicines Inititative Improving Access to High-Cost Medicines in Europe.jpg

The Oslo Medicines Initiative Improving Access to High-Cost Medicines in Europe

World Health Organization

bottom of page